{"title":"GABARAN治疗后急性胰腺炎","authors":"M. Stoicescu","doi":"10.4172/2329-6631.1000146","DOIUrl":null,"url":null,"abstract":"The main objective of this clinical-case-presentation is to attract attention that the therapy with Gabaran in high dosage and per long period of time without a careful control of function of pancreas (common dosage of amilasemia and amilasuria level) can develop unexpected severe acute pancreatitis and may put the patient’s life in danger.","PeriodicalId":15589,"journal":{"name":"Journal of Developing Drugs","volume":"18 1","pages":"1-2"},"PeriodicalIF":0.0000,"publicationDate":"2015-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Acute Pancreatitis after Therapy with GABARAN\",\"authors\":\"M. Stoicescu\",\"doi\":\"10.4172/2329-6631.1000146\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The main objective of this clinical-case-presentation is to attract attention that the therapy with Gabaran in high dosage and per long period of time without a careful control of function of pancreas (common dosage of amilasemia and amilasuria level) can develop unexpected severe acute pancreatitis and may put the patient’s life in danger.\",\"PeriodicalId\":15589,\"journal\":{\"name\":\"Journal of Developing Drugs\",\"volume\":\"18 1\",\"pages\":\"1-2\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2015-12-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Developing Drugs\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4172/2329-6631.1000146\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Developing Drugs","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2329-6631.1000146","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The main objective of this clinical-case-presentation is to attract attention that the therapy with Gabaran in high dosage and per long period of time without a careful control of function of pancreas (common dosage of amilasemia and amilasuria level) can develop unexpected severe acute pancreatitis and may put the patient’s life in danger.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
